(HealthDay)—Ingrezza (valbenazine), the first drug to treat adults with the neurological disorder tardive dyskinesia, has been approved by the U.S. Food and Drug Administration.
Apr 12, 2017
0
0
A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis. The ...
Apr 7, 2017
0
28
New King's College London research sheds light on the cellular mechanisms which enable cancer cells to escape the prostate and spread to other parts of the body.
Mar 20, 2017
0
0
A group of researchers identified a molecular machinery by which autophagy mediates secretion. These results underscore an important role of autophagy other than degradation, and will bring us to future translational research ...
Jan 10, 2017
0
0
A new role has been discovered for a well-known piece of cellular machinery, which could revolutionise the way we understand how tissue is constructed and remodelled within the body.
Dec 19, 2016
0
33
University of Kentucky College of Medicine Professor Stefan Stamm has identified a previously-unknown function of small nucleolar RNAs (snoRNAs): regulating a fundamental cellular process called alternative splicing. His ...
Oct 3, 2016
0
2
A new study by a team of scientists from the University of Malta and the Institut de Génétique Moléculaire de Montpellier (CNRS/Université de Montpellier) could help develop treatment strategies for a crippling disorder ...
Aug 1, 2016
0
4
Pediatric oncology researchers have pinpointed a crucial change in a single DNA base that both predisposes children to an aggressive form of the childhood cancer neuroblastoma and makes the disease progress once tumors form.
Nov 11, 2015
0
756
Genes may now be deleted without creating a scar in certain strains of Escherichia coli and other microorganisms, thanks to A*STAR researchers. The technique makes it easier to string together several genetic engineering ...
Sep 25, 2015
0
13
A widespread cancer-causing protein called MYC promotes the growth of tumor cells in part by ensuring that RNA transcripts are properly spliced, according to latest work from A*STAR researchers. Drugs that block parts of ...
May 13, 2015
0
15
